While insulins and GLP-1RAs have been considered equally effective at reducing HbA 1c [41, 42], a more recent meta-analysis reported that long-acting, once-weekly GLP-1RAs (exenatide and dulaglutide) achieve significantly greater reductions in HbA 1c than basal insulins such as insulin detemir, insulin glargine and insulin degludec [43]
Factors that determine your personal GLP-1 before and after results Why do some people lose 20% of their body weight while others on the same medication lose only 8%
Building healthy habits alongside your medication not only helps minimize side effects but also creates the foundation for long-term, sustainable weight loss
Anti-inflammatory agents: present and future
A longer-term gluten-elimination trial of six months produced more encouraging results
District Judge presiding over all GLP-1 stomach paralysis lawsuits to put stringent requirements in place for establishing that plaintiffs have a gastroparesis diagnosis after using the medications